Comparision of ESLAX Intravenous with Rocuronium Bromide Intravenous Solution in the incident of pain on injection

Comparision of ESLAX Intravenous with Rocuronium Bromide Intravenous Solution in the incident of pain on injection - Comparision of ESLAX Intravenous with Rocuronium Bromide Intravenous Solution in the incident of pain on injection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032466

Enrollment

Registered

2018-05-07

Start date

2018-05-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing elective surgery requiring general anesthesia and tracheal intubation

Interventions

ESLAX Intravenous Rocuronium Bromide Intravenous Solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged between 20 and 65 year,ASA physical status 1 or 2

Exclusion criteria

Exclusion criteria: patient with chronic pain

Design outcomes

Primary

Measure	Time frame
Patient response after rocuronium injection	—

Secondary

Measure	Time frame
The degree of patient response after rocuronium injection, and the result of tracheal intubation.	—

Countries

Japan

Contacts

Public ContactTachikawa Masato

Dokkyo Medical University Saitama Medical Center Anesthesiology

tachi@dokkyomed.ac.jp0489654948

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026